Skip to main navigation
Skip to search
Skip to main content
Region Zealand Home
Help & FAQ
Link opens in a new tab
Dansk
English
Search content at Region Zealand
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Courses
Press/Media
Impacts
Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus
Anders Holt
*
, Jarl E Strange
, Nina Nouhravesh
, Sebastian Kinnberg Nielsen
, Mariam Elmegaard Malik
, Anne-Marie Schjerning
, Lars Køber
, Christian Torp-Pedersen
, Gunnar H Gislason
, Patricia McGettigan
, Morten Schou
, Morten Lamberts
*
Corresponding author for this work
Cardiology
Research output
:
Contribution to journal
›
Article
›
Research
›
peer-review
Overview
Fingerprint
Fingerprint
Explore the research areas of 'Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus'.
Sort by
Weight
Alphabetically
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Heart Failure
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
100%
Type 2 Diabetic Patients
30%
Heart Failure Hospitalization
30%
Short-term Use
20%
Danish Registers
10%
Hemoglobin A1c (HbA1c)
10%
Endothelial Dysfunction
10%
HbA1c Levels
10%
Cardiomyopathy
10%
Exposure Windows
10%
Advanced Age
10%
Fluid Retention
10%
Case-crossover Design
10%
A1c Levels
10%
Rheumatic Diseases
10%
New User
10%
Incident Heart Failure
10%
Physician Prescribing Patterns
10%
Heart Disease Risk
10%
Antidiabetic Drug
10%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Nonsteroid Antiinflammatory Agent
100%
Congestive Heart Failure
60%
Patient with Type 2 Diabetes
30%
Hemoglobin A1c
20%
Antidiabetic Agent
10%
Kidney Function
10%
Endothelial Dysfunction
10%
Myocardial Disease
10%
Identified Patient
10%
Drug Prescription
10%
Fluid Retention
10%
Rheumatic Disease
10%
Nursing and Health Professions
Nonsteroid Antiinflammatory Agent
100%
Maturity Onset Diabetes of the Young
100%
Congestive Heart Failure
60%
Patient with Type 2 Diabetes
30%
Hemoglobin A1c
20%
Antidiabetic Agent
10%
Endothelial Dysfunction
10%
Rheumatic Disease
10%
Myocardial Disease
10%
Pharmacology, Toxicology and Pharmaceutical Science
Non-Steroidal Anti-Inflammatory Drug
100%
Maturity Onset Diabetes of the Young
100%
Congestive Heart Failure
60%
Hemoglobin A1c
20%
Endothelial Dysfunction
10%
Antidiabetic Agent
10%
Rheumatic Disease
10%
Myocardial Disease
10%
Neuroscience
Diabetes Mellitus
100%
Non-Steroidal Anti-Inflammatory Drug
100%
Hemoglobin A1c
20%
Myocardial Disease
10%